Predictive modeling for cell culture in commercial manufacturing of biotherapeutics.
Biotechnol Bioeng
; 121(11): 3440-3453, 2024 Nov.
Article
en En
| MEDLINE
| ID: mdl-39023310
ABSTRACT
The biopharmaceutical industry continually seeks advancements in the commercial manufacturing of therapeutic proteins, where mammalian cell culture plays a pivotal role. The current work presents a novel data-driven predictive modeling application designed to enhance the efficiency and predictability of cell culture processes in biotherapeutic production. The capability of the cloud-based digital data science application, developed using open-source tools, is demonstrated with respect to predicting bioreactor potency from at-line process parameters over a 5-day horizon. The uncertainty in model's prediction is quantified, providing valuable insights for process control and decision-making. Model validation on unseen data confirms the model's robust generalizability. An interactive dashboard, tailored to process scientist's requirements is also developed to streamline biopharmaceutical manufacturing processes, ultimately leading to enhanced productivity and product quality.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Productos Biológicos
/
Técnicas de Cultivo de Célula
/
Reactores Biológicos
Límite:
Animals
Idioma:
En
Revista:
Biotechnol Bioeng
Año:
2024
Tipo del documento:
Article
País de afiliación:
Estados Unidos